GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) » Definitions » Total Assets

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Total Assets : ¥3,835 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Bio-Sincerity Pharma-Tech Co Total Assets?

Hangzhou Bio-Sincerity Pharma-Tech Co's Total Assets for the quarter that ended in Mar. 2024 was ¥3,835 Mil.

Warning Sign:

If a company builds assets at 104.7% a year, faster than its revenue growth rate of 46% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Hangzhou Bio-Sincerity Pharma-Tech Co's average Total Assets Growth Rate was 55.00% per year. During the past 3 years, the average Total Assets Growth Rate was 74.40% per year. During the past 5 years, the average Total Assets Growth Rate was 104.70% per year.

During the past 7 years, Hangzhou Bio-Sincerity Pharma-Tech Co's highest 3-Year average Total Assets Growth Rate was 128.00%. The lowest was 74.40%. And the median was 105.05%.

Total Assets is connected with ROA %. Hangzhou Bio-Sincerity Pharma-Tech Co's annualized ROA % for the quarter that ended in Mar. 2024 was 5.31%. Total Assets is also linked to Revenue through Asset Turnover. Hangzhou Bio-Sincerity Pharma-Tech Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.06.


Hangzhou Bio-Sincerity Pharma-Tech Co Total Assets Historical Data

The historical data trend for Hangzhou Bio-Sincerity Pharma-Tech Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Bio-Sincerity Pharma-Tech Co Total Assets Chart

Hangzhou Bio-Sincerity Pharma-Tech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial 378.63 658.75 2,924.87 2,929.71 3,669.11

Hangzhou Bio-Sincerity Pharma-Tech Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,246.05 3,381.52 3,406.10 3,669.11 3,834.69

Hangzhou Bio-Sincerity Pharma-Tech Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Hangzhou Bio-Sincerity Pharma-Tech Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=2684.137+984.969
=3,669

Hangzhou Bio-Sincerity Pharma-Tech Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=2741.389+1093.302
=3,835

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Bio-Sincerity Pharma-Tech Co  (SZSE:301096) Total Assets Explanation

Total Assets is connected with ROA %.

Hangzhou Bio-Sincerity Pharma-Tech Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=199.272/( (3669.106+3834.691)/ 2 )
=199.272/3751.8985
=5.31 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Hangzhou Bio-Sincerity Pharma-Tech Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=215.703/( (3669.106+3834.691)/ 2 )
=215.703/3751.8985
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Hangzhou Bio-Sincerity Pharma-Tech Co Total Assets Related Terms

Thank you for viewing the detailed overview of Hangzhou Bio-Sincerity Pharma-Tech Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Business Description

Traded in Other Exchanges
N/A
Address
611 Dongguan Road, 2nd Floor, Building 8, Jinsheng Technology Park, Binjiang District, Hangzhou, CHN
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Headlines

No Headlines